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Residual HIV-1 DNA Flap-independent nuclear
import of cPPT/CTS double mutant viruses does
not support spreading infection
Candela Iglesias1,2†, Mathieu Ringeard1,3†, Francesca Di Nunzio1, Juliette Fernandez1, Raphael Gaudin1,4,
Philippe Souque1, Pierre Charneau1* and Nathalie Arhel1*
Abstract
Background: The human immunodeficiency virus type 1 (HIV-1) central DNA Flap is generated during reverse
transcription as a result of (+) strand initiation at the central polypurine tract (cPPT) and termination after a ca. 100
bp strand displacement at the central termination sequence (CTS). The central DNA Flap is a determinant of HIV-1
nuclear import, however, neither cPPT nor CTS mutations entirely abolish nuclear import and infection. Therefore,
to determine whether or not the DNA Flap is essential for HIV-1 nuclear import, we generated double mutant
(DM) viruses, combining cPPT and CTS mutations to abolish DNA Flap formation.
Results: The combination of cPPT and CTS mutations reduced the proportion of viruses forming the central DNA
Flap at the end of reverse transcription and further decreased virus infectivity in one-cycle titration assays. The
most affected DM viruses were unable to establish a spreading infection in the highly permissive MT4 cell line, nor
in human primary peripheral blood mononuclear cells (PBMCs), indicating that the DNA Flap is required for virus
replication. Surprisingly, we found that DM viruses still maintained residual nuclear import levels, amounting to 5-
15% of wild-type virus, as assessed by viral DNA circle quantification. Alu-PCR quantification of integrated viral
genome also indicated 5-10% residual integration levels compared to wild-type virus.
Conclusion: This work establishes that the central DNA Flap is required for HIV-1 spreading infection but points to
a residual DNA Flap independent nuclear import, whose functional significance remains unclear since it is not
sufficient to support viral replication.
Background
During infection, the reverse transcriptase (RT) of retro-
viruses converts the (+) strand RNA genome into dou-
ble-stranded DNA prior to nuclear import. Similar to all
DNA polymerases, the retroviral RT requires the 3’ OH
of a primer to initiate polymerisation. The primer used
for (-) strand synthesis is a cellular tRNA already pre-
sent in the retroviral particles prior to infection and
anneals to the 5’ region of the genome at the primer
binding site (PBS). The primer used for (+) strand
synthesis is a polypurine tract (PPT) present in the 3’
region of the RNA genome that resists RNase H
degradation concomitant with (-) strand synthesis. The
genome of lentiviruses contains two such cis-acting pur-
ine-rich sequences: the 3’PPT common to all retro-
viruses and an additional central PPT present in the
coding sequence of the integrase. The resulting initia-
tion of (+) strand synthesis at the cPPT as well as at the
3’PPT leads to a (+) strand discontinuity at the centre of
lentiviral genomes [1-5].
Similar to central (+) strand initiation, the termination
of reverse transcription is a further feature that distin-
guishes lentiviruses from other orthoretroviruses. For
most retroviruses, termination occurs when the RT
reaches the 5’ end of the template. In the case of lenti-
viruses however, such as HIV-1 [6], EIAV [4], and FIV
[5], reverse transcription terminates ca. 100 nt down-
stream of the cPPT at stretches of A and T nucleotides
(the central termination sequence, CTS) whose
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conformation disfavours binding to RT enzyme and thus
halts reverse transcription. As a result of the cPPT and
CTS cis-acting sequences, the final product of lentiviral
reverse transcription contains a ca. 100 nt overlap, or
“DNA Flap”, at the centre of the genome.
Mutations introduced either in the cPPT [7-9] or in
the CTS [6] of HIV-1 lead to a loss of HIV-1 infectivity
that is proportional to the number and positional impact
of introduced mutations. The conversion of cPPT pur-
ines into pyrimidines compromises central initiation of
(+) strand synthesis and thus central DNA Flap forma-
tion [7]. Similarly, the mutation of dAn-dTn tracts in the
CTS leads to aberrant (+) strand termination events
spread over a distance of over 500 nt downstream of the
cPPT [6]. Therefore, both the cPPT and CTS are
required to form a functional central DNA Flap, and
HIV-1 infection is impaired if either are mutated.
The defect in viral replication observed for cPPT
mutant viruses [7,10,11] is not accounted for by defects
in viral DNA synthesis, integration, or virus production
[9] but by a defect in nuclear import [9,10,12]. The
importance of the central DNA Flap for nuclear import
was harnessed by the gene therapy field when it was
shown that re-insertion of the cPPT and CTS sequences
in lentiviral vectors significantly enhanced gene transfer
efficiencies by increasing nuclear import [9,13]. It is
now systematically included in lentiviral vectors.
Interestingly, central (+) strand initiation has been
shown to protect the HIV-1 genome from editing by
cytidine deaminases of the APOBEC3 family down-
stream of the cPPT sequence [14]. Protection was high
closest to the cPPT and decreased progressively further
downstream. APOBEC3 enzymes edit exclusively single-
stranded DNA, which in the case of HIV corresponds to
the newly-synthesised (-) strand DNA. Editing is possi-
ble only until synthesis of the complementary (+) strand.
Therefore, sequences immediately downstream of (+)
strand initiation PPT sequences are more protected
from editing than those upstream or further down-
stream [14,15]. It has been suggested that APOBEC3G/F
editing wholly accounts for the infectivity defect of
cPPT mutant HIV [16]. However, the benefit of the cen-
tral DNA Flap is not contested in the context of HIV-1-
derived vectors, which are standardly produced in APO-
BEC3G-negative 293T cells [5,9,10,12,13,17-34]. Further-
more, in the case of CTS mutants, a (+) strand segment
is correctly initiated at the cPPT [6] and should protect
downstream sequences from deamination as in wild-
type virus. Therefore, the observed strong replication
defect of CTS mutants in Vif non-permissive cells [16]
cannot be attributed to APOBEC3G restriction.
Nevertheless, the importance of the central DNA Flap
for HIV-1 nuclear import, infectivity and replication in
vivo has been a source of much debate over the past 10
years. Some papers have proposed that the central DNA
Flap contributes minimally, if at all, to HIV-1 replica-
tion, although some degree of impairment for DNA Flap
mutants is observed in human PBMCs and macrophages
[16,35-38]. However, other studies claim that the central
DNA Flap plays an important role in HIV nuclear
import, infectivity, transduction efficiency, and viral
replication [6,7,9-13,17-34,39]. Therefore, the debate
seems really to reside in whether the central DNA Flap
is essential for infection and replication, or whether it
merely contributes towards rendering these more
efficient.
Mutations in the cPPT do not lead to totally non-
infectious viruses [6,7] and some residual HIV-1 nuclear
import is observed [10], suggesting either that viruses
may enter the nucleus in a DNA-Flap-independent man-
ner or that the mutations introduced in the cPPT are
not sufficient to abolish DNA Flap formation. Unfortu-
nately, the extent of mutations that can be introduced
in the cPPT is limited by the need to maintain a func-
tional integrase. The 225T mutant [17], which contains
6 synonymous mutations, maintains residual infectivity
probably because the cPPT is only partially inactivated.
To more profoundly disrupt DNA Flap formation, the
cPPT-D mutant was generated to contain an additional
K®R amino acid change and compared with a control
virus cPPT-AG containing the same K®R mutation, but
maintaining the polypurine nature of the cPPT [9].
Despite non-detectable (+) strand discontinuity, the
cPPT-D mutant still retained residual infectivity and
nuclear import (5-10% of wild-type HIV-1) [9]. There-
fore, it remains an open question whether observed resi-
dual infection is due to only partial disruption of the
DNA Flap, or whether a DNA-Flap-independent nuclear
import exists in ca. 10% of infectious events. Since we
cannot introduce any further mutations in the cPPT, we
set out to combine cPPT mutations with the previously
described CTS mutant that leads to aberrant (+) strand
termination [6], on the premise that residual central
strand initiation will then not lead to functional DNA
Flap formation. We thus report the generation of fully
disruptive mutants for DNA Flap formation that pre-
serve integrase function, and document their effect on
nuclear import, infectivity and replication.
Results
Production of wild-type and mutant viruses
In HIV-1, the cPPT sequence is an exact copy of the
3’PPT and is composed sequentially of a T-box, two A-
boxes and a G-box (Figure 1). We previously found that
the two A-boxes have the most profound impact on
HIV-1 infectivity when mutated, followed in importance
by the G- and lastly the T-box (P. Charneau, unpub-
lished data). The 223 mutant, which introduces two
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pyrimidines in the A-boxes, is one of the least affected
mutants [7]. The 225T mutant combines mutations in
all four boxes and is the most affected amongst the
synonymous cPPT mutants [17]. The addition of a sin-
gle non-synonymous mutation (cPPT-D mutant) has the
most profound effect on viral replication [9]. Although
this mutant introduces an amino acid change at position
188 of the integrase coding region (K188R), the control
virus (cPPT-AG) with the same amino acid change
behaved like wild-type virus in terms of virus production
and viral DNA synthesis [9]. Position 188 of integrase
(IN) is important for salt bridge formation between the
catalytic core and the N-terminal domain, however, the
presence of an arginine rather than a lysine at this posi-
tion is naturally found in HIV-2 IN and does not per-
turb salt bridge formation [40]. The previously described
CTS mutant, which was designed to disrupt the dAn-
dTn tracts of the CTS while respecting the correspond-
ing integrase amino acid sequence, results in DNA Flaps
of abnormal length and severely impairs infectivity [6].
We generated double mutants (DM) by combining in
HIV-1LAI and HIV-1LAI ∆env-vsvG viruses, the 223,
225T or cPPT-D cPPT mutants with the previously
described CTS mutation [6]. There were no appreciable
differences in virus p24 concentration between the wild-
type virus and any of the mutant viruses (Additional
File 1 Figure S1), confirming that DNA Flap mutations
do not affect virus production [9].
Impact of DNA Flap mutations in single-cycle infectivity
We first tested the single and double mutant viruses for
infectivity in single cycle infections in the P4-CCR5
reporter cell line, which are HeLa CD4+ CXCR4+ CCR5
+ carrying the Lac Z gene under the control of the
HIV-1 LTR promoter [6]. cPPT and CTS HIV-1
mutants exhibited an impairment of infection that was
significant and increasingly important with increasing
number of mutations (Figure 2A). Reduction was consis-
tent and was of 2-, 14-, 16- and 20-fold for 223, CTS,
cPPT-D and 225T, respectively, compared to wild-type
virus (Figure 2B). The combination of cPPT and CTS
mutations increased this defect significantly in the case
of the DM-223 and DM-D mutants. The DM-D mutant
was the most affected of all DNA Flap mutants and only
retained a very residual infectivity of 0.8 +/- 0.3% of
wild-type virus (Figure 2B). The pseudotyping of HIV-1
with the vesicular stomatitis virus glycoprotein (VSV-G),
which confers broad tropism and increases infectivity by
10-fold, attenuated the infectivity defects observed with
wild-type envelope HIV-1LAI viruses (Figure 2C). The
average reduction in infectivity was between 2- and 5-
fold for all single mutants. However, the combining of
cPPT and CTS mutations significantly further decreased
the infectivity of pseudotyped viruses. The most affected
mutant, DM-D VSV-G, retained an infectivity of 9.4 +/-
0.9% of wild-type virus (Figure 2D).
Taken together, these results indicate that all cPPT
single and double mutants are severely impaired in
infectivity, but that the most disrupted mutant still
maintains residual infection (ca. 1% for non-pseudo-
typed viruses and ca. 10% for VSV-G pseudotyped
viruses) in a one-round titration assay.
It has recently been reported that central DNA Flap
mutant HI-viruses maintain wild-type infectivity in sin-
gle cycle infection assays following production in APO-
BEC3G-negative 293T cells [16]. To test the possibility
that the apparent discrepancy between our results and
those reported by Hu et al. 2010 [16] might reflect dif-
ferences between virus strains or the production proto-
col, the molecular clones used in Hu et al. were
obtained from E. Poeschla (Mayo Clinic). The ability of
these viruses to infect P4-CCR5 indicator cells was
tested in parallel with our wild-type virus and DNA Flap
mutants. The mutants from both studies displayed a
comparable infectivity defect (up to 10-fold) at all multi-
plicities of infection tested (Figure 2E).
To test the possibility that the discrepancies between
our results and those from Hu et al. might result from
the use of different indicator cell lines, the GHOST3
AAA CAA ATT ACA AAA ATT CAA AAT TTTCTS wild-type
AAA CAG ATC ACG AAG ATC CAG AAC TTCCTS mutated
lys gln ile thr lys ile gln asn phe
  T TTT AAA AGA AAA GGG GGGcPPT wild-type
  T TTT AAA CGC AAA GGG GGGcPPT-223
phe lys arg lys gly gly
  C TTC AAA CGC AAA GGT GGTcPPT-225T
  C TTC AAG CGC CGC GGT GGTcPPT-D
phe lys arg arg gly gly
185 190
215 223
185 190
  T TTT AAA AGA AGA GGG GGGcPPT-AG
Figure 1 Mutations introduced in the cPPT and/or CTS regions
of HIV-1LAI. The 223 mutation introduces two pyrimidines in the A-
boxes, and the 225T mutant is derived from the 225 mutant, which
contains two additional pyrimidines in the G-box. The T mutation
refers to the introduction of two cytosines in the T-box. The cPPT-D
mutation [9] corresponds to the 225T mutant with 4 additional
mutations in A-boxes, totalling to 10 mutations in the 19-mer cPPT.
The CTS mutant has a total of 8 mutations in the ter1 and ter2
domains [6]. Numbers indicate amino acid positions in HIV-1 IN.
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Figure 2 Single-cycle titration assay in P4-CCR5 cells indicate an increased infectivity defect of DNA Flap double mutant viruses
compared with cPPT or CTS single mutants. (A) P4-CCR5 cells were infected with 4 ng or 1 ng p24 of HIV-1 wild-type envelope and
infectivity was measured 48 h p.i by tat transactivation of the beta-gal promoter (mean of triplicates +/- SD representative of two independent
experiments). (B) Relative infection of the DNA Flap mutant viruses compared with wild-type LAI virus (mean of three independent experiments
carried out in triplicate over a range of viral concentrations +/- SD). Statistical relevance was calculated using paired t test to compare cPPT
single mutant viruses with their corresponding DM virus, *** p < 0.001. (C) P4-CCR5 cells were infected with 1 ng or 0.1 ng p24 of HIV-1 VSV-G
and infectivity was measured 48 h p.i by Tat transactivation of the beta-gal promoter (mean of triplicates +/- SD representative of three
independent experiments). (D) Relative infection of the DNA Flap mutant viruses compared with wild-type LAI virus (mean of three independent
experiments carried out in triplicate +/- SD). Statistical relevance was calculated using paired t test to compare cPPT single mutant viruses with
their corresponding DM virus, *** p < 0.001. (E) P4-CCR5 cells were infected with wild-type env NL4-3 viruses from the Hu et al., 2010 study (WT,
mcPPT, DM) in parallel with our wild-type and mutant LAI viruses (LAI, D, DM D). Results show the mean beta-galactosidase activity of duplicates
+/- SD and are representative of three independent experiments. (F) GHOST3 cells were infected with increasing doses of viruses from the Hu et
al. study [16]. Infectivity was assessed at 48 h p.i using flow cytometry. Results show the mean percentage of GFP positive cells of three
independent experiments.
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cells used in the Hu et al. study were obtained also from
E. Poeschla and infected in parallel with molecular
clones from Hu et al. and our wild-type and mutant
viruses (Figure 2F and Additional File 2 Figure S2).
GHOST3 cells are HOS CD4+ CXCR4+ CCR5+ carry-
ing the green fluorescent protein (GFP) gene under the
control of the HIV-2 LTR promoter. This reporter cell
line has the advantage that it does not require cell lysis
or addition of substrate, and allows for percentages of
infected cells to be measured. We note however that
percentages of infected cells have a reduced dynamic
range (0-100%, Figure 2F), compared with RLU values
from P4-CCR5 cells (4-5 log10, Figure 2A, C), and do
not distinguish single from multiple integration events.
The percentage of infected cells was consistently less for
DNA Flap mutants compared with wild-type virus (up
to 6-fold), but the amplitude of the infectivity defect was
reduced or lost at high multiplicities of infection (Figure
2F), where multiple integration events occur. The nar-
row linear dynamic range of GHOST3 cells may account
for the diverging results reported by Hu et al. [16].
Impact of DNA Flap mutations on viral replication
Single cycle infection assays are sensitive to very low
infectivity and successful integration events as measured
by beta-gal activity, but do not guarantee that the
viruses can establish a spreading infection in cell cul-
ture. We therefore carried out kinetics of replication fol-
lowing infection with wild-type envelope HIV-1. MT4
cells were chosen because they are highly permissible to
HIV-1, allowing rapid and efficient replication. MT4
cells are APOBEC3G-negative, and therefore the role of
central (+) strand initiation in protecting the genome
from editing [14,16] is not a confounding factor in this
assay. In 2 independent experiments, the replication of
wild-type HIV-1LAI peaked at 5-6 days post infection; in
contrast, the replication of 223, 225T, CTS and cPPT-D
single mutants was delayed on average by 3, 5, 6 and 9
days, respectively, compared with wild-type HIV-1LAI
(Figure 3). While DM-223 showed a delay similar to
that of the CTS mutant, virus replication remained
undetectable for DM-225T and DM-D mutants over the
24-day period, indicating that despite minimal single-
cycle infection, these viruses do not replicate in the time
frame of the assay.
To verify that the observed replication defect is not
cell-dependent, we also tested the ability of double-
mutant viruses to establish spreading infection in
human primary PBMCs from two healthy donors, which
were infected with 0.1 and 1 ng p24 of wild-type and
double mutant viruses. The replication of wild-type
HIVLAI peaked at 7-10 days post-infection (Figure 4). In
contrast, no peak of replication was detected for double
mutant viruses over the 40-day period, and virus
concentration was only sporadically measurable above
the assay minimum detectable limit (ca. 3 ng/ml). The
fact that DM 223, which replicated in MT4 cells despite
some delay compared to wild-type virus (Figure 3), did
not establish spreading infection in PBMCs confirms the
high permissiveness of MT4 cells. Moreover, although
viruses used for this study were wild-type for Vif, the
stronger block in replication observed in PBMCs may
also reflect the increased sensitivity of DNA Flap
mutants to APOBEC3G/F-mediated deamination in
PBMCs [14,16]. We conclude that DNA Flap double
mutant viruses cannot establish spreading infection in
Figure 3 Replication kinetics in MT4 cells indicate an increased
replication defect of DNA Flap double mutant viruses
compared with cPPT or CTS single mutants. MT4 cells were
infected with 1 ng p24 of wild-type envelope HIV-1 and virus
production was measured at given time points post-infection by
performing RT assay on the culture supernatants. Results show the
mean of triplicates +/- SEM and are representative of two
independent experiments.
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lymphocytic cell cultures despite detectable levels of
infectivity in single cycle infection assays.
Impact of DNA Flap mutations on nuclear import
Once reverse transcribed in the cytoplasm, the HIV-1
linear DNA is imported into the nucleus where it either
integrates or circularises. Circular forms of non-inte-
grated viral DNA contain one or two long terminal
repeats (LTR) and are thought to be dead-end products
of infection. Since they are found exclusively in the
nucleus of infected cells, they constitute convenient
markers of nuclear import. We therefore used quantita-
tive PCR to measure two-LTR DNA circles [41] in P4-
CCR5 cells infected with wild-type, single and double
mutant HIVLAI vsvG viruses. At 24 h post-infection,
quantification of 2-LTR junctions revealed a reduction
in 2-LTR copy numbers of 3-6-fold for all single and
double DNA Flap mutants compared to wild-type virus,
indicating a defect in nuclear import (Figure 5A). As
previously observed (P. Charneau, unpublished data),
the CTS mutant has a nuclear import defect comparable
to cPPT mutants. Mutations in the cPPT lead to linear
DNA lacking the central DNA Flap while mutations in
the CTS lead to linear DNA containing an aberrantly
sized DNA Flap. Since both DNA Flap mutant types
have impaired nuclear import, it is the integrity of the
DNA Flap structure, rather the presence or not of a (+)
strand discontinuity, that accounts for nuclear import.
Furthermore, DNA Flap mutant viruses maintained a
defect in 2-LTR copy numbers over a 72 h time course
(Figure 5B), indicating an overall defect in nuclear
import rather than a delay. D vsv-G and DM-D vsv-G
viruses remained strongly defective for nuclear import
throughout the time course (Figure 5B). Similar to
results obtained from infectivity experiments (Figure 2),
the combination of cPPT and CTS mutants led to a
further decrease in 2-LTR copy numbers compared with
single mutants. Using this test, DM-225T and DM-D
maintain residual levels of 2-LTR circles of 10-20% of
wild-type virus, indicating that disruption of the central
DNA Flap severely impairs but does not abrogate
nuclear import.
Figure 4 Replication kinetics in primary PBMCs indicate an inability of double mutant viruses to establish spreading infection. PBMCs
were infected with 0.1 and 1 ng p24 of wild-type envelope HIV-1, and virus production was measured at given time points post-infection by
p24 ELISA on the culture supernatants. Results show the mean of duplicates +/- SEM for two donors.
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Two-LTR circles represent only a minute fraction of
HIV-1 DNA in infected cells (< 1% of nuclear viral
DNA), and small variations in their levels will lead to
important changes in inferred nuclear import levels.
One-LTR circles are more abundant (ca. 35% of nuclear
viral DNA) [9], but cannot be distinguished by quantita-
tive PCR. We therefore used restriction enzyme analysis
coupled to Southern blotting to detect total, linear non-
integrated, and circularised forms of HIV-1 DNA in
MT4 cells [9]. In three independent experiments, we
found that at 48 h post-infection with wild-type HIV-
1LAI, under 1% of viral DNA was in the form of 2-LTR
circles, 35-45% as 1-LTR circles, and 10-15% as linear
unintegrated DNA (Figure 6A), which is concordant
with previous work [9]. Linear viral DNA molecules
undergo rapid integration or circularisation soon after
entry in the nucleus [42-45]; therefore, measured linear
DNA corresponds predominantly to cytoplasmic viral
DNA, and its accumulation is indicative of a nuclear
import defect. The ratio of 1- and 2-LTR forms over lin-
ear cytoplasmic viral DNA at 48 h post-infection, which
was of 4 on average for wild-type HIV-1, was reduced,
A
B
Figure 5 Quantification of 2-LTR circles and total HIV-1 DNA
(Pol) by quantitative PCR shows defects in nuclear import for
all DNA Flap mutants. P4-CCR5 cells were infected with wild-type
and DNA Flap mutant viruses pseudotyped with VSV-G envelope.
(A) Results show the number of 2-LTR circles normalised for pol
copy numbers at 24 h post-infection. Non-infected samples did not
give rise to amplified products. Cells infected in the presence of
Nevirapine served as controls for each virus infection (< 103 copies
for all samples) and were subtracted from each value. Values are
represented as a percentage of wild-type and are the mean of 3
independent experiments carried out in duplicate +/- SEM. (B)
Results show 2-LTR circles at given time points post-infection,
normalised for pol copy number at 24 h post-infection. Values are
represented as a percentage of wild-type at 48 h post-infection and
are the mean of 2 independent experiments carried out in
duplicate +/- SEM.
2 LTR
1 LTR
Linear
Total
LAI   D   DM-D
LAI  225T  DM-225T
2 LTR
1 LTR
Linear
Total
LAI   CTS  223  DM-223
2 LTR
1 LTR
Linear
Total
A
B
Figure 6 Quantification of LTR circles, linear unintegrated, and
integrated HIV-1 DNA by Southern blotting and Alu-PCR
confirms defects in nuclear import for all DNA Flap mutants.
(A) MT4 cells were infected with wild-type or DNA Flap mutant
viruses pseudotyped with VSV-G envelope. Total DNA was isolated
48 h post-infection and intracellular viral DNA forms were analysed
by Southern blotting. Bands were quantified using Phosphorimager
and nuclear import was assessed by plotting the ratio of LTR circles
(nuclear) to linear non-integrated HIV-1 (predominantly cytoplasmic).
(B) Assessment of HIV-1 integration by Alu-PCR. The graph shows
mean values of 3 independent experiments +/- SEM.
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in the case of mutations in the cPPT, to 0.2-0.6 indicat-
ing a nuclear import defect (Figure 6A). Using this
Southern blot assay, we did not notice an additional
impairment of nuclear import for DM viruses. Further-
more, despite the reduction in nuclear import, nuclear
forms of viral DNA (1-LTR) could still be detected for
both single and double DNA Flap mutants, confirming
the residual level of nuclear import obtained with 2-
LTR quantitative PCR.
While these findings suggested that a residual propor-
tion of viral pre-integration complexes might enter the
nucleus in the absence of the central DNA Flap, we
could not exclude that a small proportion of DNA cir-
cles form independently of nuclear import, through
auto-integration events in the cytoplasm for instance
[45]. To verify this, we quantified integrated viral DNA
using Alu-PCR. If viral DNA circularisation occurs inde-
pendently of HIV-1 nuclear import or at the expense of
HIV-1 integration, which is essential for productive
infection, integrated viral DNA would not be detected
following infection with DNA Flap mutant viruses. We
found that cPPT and CTS mutations led to significant
reduction in detected integrated HIV-1 genome and that
the combination of cPPT and CTS mutations in double
mutants led to even greater defects in integration (Fig-
ure 6B). The integration defect for the 223 mutant was
only 2-fold, which is concordant with the single cycle
infectivity and quantitative PCR of 2-LTR circles data
(Figure 2). Importantly, integrated signal could be
detected for all viruses, including the most disrupted
DM-D virus, equivalent to 5-10% of wild-type levels,
consistent with the result that all mutant viruses have
some residual nuclear import.
Taken together, our data indicate that all DNA Flap
mutants analysed have a strongly impaired nuclear
import, but maintain a residual level of nuclear import
which amounts to 5-15% of wild-type HIV-1, depending
on the assay used. The mechanism for this DNA-Flap-
independent nuclear import is unknown. The propor-
tion of circularised and integrated HIV-1 following
nuclear import is similar to that observed for wild-type
virus. However, levels of integrated virus are insufficient
to establish spreading infection.
Discussion
The central DNA Flap is an important determinant of
HIV-1 nuclear import, but previously described cPPT
mutants still maintain minimal nuclear import (of ca.
10% of wild-type virus) resulting in residual infection in
single-cycle titrations. The previous lack of sufficiently
disruptive cPPT mutants has prevented us from con-
cluding whether these residual levels are due to incom-
plete disruption of the DNA Flap or whether they point
to a DNA-Flap-independent nuclear import. In this
study, we combined cPPT and CTS mutations to ensure
that possible (+) strand central initiation in 10% of
cPPT mutant viruses will not lead to the formation of
functional DNA Flap. We found that the most affected
double mutants were unable to establish spreading
infection in the highly permissive MT4 cells, indicating
that the DNA Flap is required for virus replication. Sur-
prisingly, all DNA Flap mutants, including the most dis-
rupted, maintained residual nuclear import levels
amounting to 5-15% of wild-type levels.
Our results reveal an apparent discrepancy between
the detected residual nuclear import and the absence of
spreading infection in lymphocytic cells. A residual pro-
portion of viral pre-integration complexes might enter
the nucleus in the absence of the central DNA Flap, but
poor efficiency, low numbers or sub-optimal integration
may be detrimental for viral replication. It has been sug-
gested that APOBEC editing wholly accounts for the
infectivity defect of cPPT mutant HIV [16]. While we
cannot exclude a minor contribution of APOBEC edit-
ing to the phenotypes we observe, it cannot entirely
contribute to the replication defect of DNA Flap mutant
viruses since the most defective DNA Flap mutants
were unable to establish spreading infection in MT4
cells, which are APOBEC3G-negative.
The DNA Flap controversy
The central DNA Flap and its importance for HIV-1
replication have been controversial for many years. Its
role as a cis-acting determinant of nuclear import has
proven all-important for gene transfer based on lenti-
viral vectors and in the context of replicative viruses
[5,9-13,17-21,23,24,26-31,33,34,39]. This defect is inde-
pendent of envelope tropism (R5, X4, VSV-G) or cell
type used (cell lines, primary lymphocytes, APOBEC3G/
F status). Still, a certain element of contention remains
regarding the extent of the DNA Flap’s importance,
with some reports contesting its role in nuclear import
and replication [16,35-38].
We believe this controversy may be resolved by con-
sidering two points. Firstly, the benefit to infection/
transduction brought by the central DNA Flap will be
overseen in saturating experimental conditions with
assays that cannot distinguish single from multiple
infectious events per cell. Concordantly, high MOIs in
the context of lentiviral transductions attenuate defects
measured in the absence of the central DNA Flap [11].
Similarly, this paper shows that the infectivity defect of
DNA Flap mutants is more apparent for wild-type
envelope HIV-1 than for VSV-G pseudotyped HIV-1,
which is 10-fold more infectious; and more apparent in
PBMCs than MT4 cells, which are highly permissive. In
transduction experiments using HIV-1 derived vectors
coding for eGFP, the benefit of the DNA Flap in terms
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of the percentage of transduced cells will also decrease
with increasing MOI, with transduction efficiencies that
can reach 100% for both Flap+ and Flap- vectors in per-
missive cells (Figure 7). The same loss of a differential
phenotype at high and low MOI was also observed fol-
lowing infection of GHOST cells with the viruses from
the Hu et al., 2010 study (Figure 2F). In contrast, the
difference in mean fluorescent intensity (MFI), which
reflects cumulative nuclear entry events, will increase
(Figure 7). Therefore, in the case of multiple infectious
events per cell, the true impact of the central DNA Flap
may only be reliably assessed by combining both per-
centage of infected cells and MFI [31].
Secondly, DNA Flap mutant viruses display an equal
nuclear import defect in both dividing and non-dividing
cells [9,10,39,46]. Therefore, assays that compare cycling
cells with aphidicolin-arrested cells will invariably see no
difference in terms of nuclear import and infectivity of
DNA Flap mutant viruses. These experiments are based
on the hypothesis that HIV-1 passes through the nuclear
pore in non-dividing cells, but uses an alternative route
for nuclear entry during mitosis. However, several argu-
ments suggest that this might not be the case. (1) A
mitosis-independent nuclear import in cycling cells has
been reported [47]. (2) A genome-wide RNA interfer-
ence-based screen comparing HIV-1 and MLV infec-
tions identified unique nuclear import factors for HIV-1
even though the study was carried out in cycling cells
[48]. (3) The assumption that HIV-1 might passively
gain access to the chromatin upon mitosis, if based on
the belief that cytoplasmic and nuclear contents mix
homogeneously throughout mitosis, is not valid. Indeed,
evidence suggests that mitotic cells maintain spatial
information through gradients, such as the RanGTP gra-
dient that surrounds chromatin [49,50]. (4) HIV-1
mutants with a nuclear import defect in cell cycle-
arrested cells often maintain this defect in cycling cells
[9,10,39,46,51]. (5) The replication of certain lentiviruses
(such as EIAV, CAEV and VISNA) is entirely limited to
macrophages, which do not divide.
Mechanism of DNA-Flap-dependent nuclear import
We have previously shown that the central DNA Flap
mediates nuclear import by promoting viral capsid
uncoating at the nuclear pore [17]. However, the mole-
cular mechanisms underlying DNA-Flap-dependent
maturation of HIV-1 capsids remain unknown. Since
DNA-Flap-dependent uncoating can be reconstituted in
vitro in purified vector particles undergoing endogenous
reverse transcription, it is not likely that any cellular
component(s) is implicated in the uncoating process
unless it is already present in the particle. One possible
hypothesis is that formation of the central DNA Flap at
the end of reverse transcription triggers major morpho-
logical rearrangements that lead to the release of the
HIV-1 pre-integration complex from the capsid core.
Intriguingly, CTS mutations, which lead to DNA Flap
structures with aberrant length spread over a distance of
500 nt downstream of the cPPT [6], severely impair
nuclear import and infectivity. These data suggest that a
central DNA Flap of aberrant length is as detrimental to
viral replication as is the absence of the central DNA
Flap.
Mechanism of DNA-Flap-independent nuclear import
The mechanism for the DNA-Flap-independent nuclear
import uncovered by this study is unknown, but evi-
dence suggests that it might involve at least some of the
same host factors as DNA-Flap dependent nuclear
import since Flap-negative viruses are as sensitive to the
depletion of TNPO3 or Nup153 as wild-type virus
[52,53]. DNA Flap-independent nuclear import cannot
be due to viral complexes entering the nucleus via an
alternative route during mitosis, since the DNA-Flap-
Figure 7 Effect of the central DNA Flap on percentage of
transduced cells and mean fluorescent intensity upon
increasing MOI. HeLa cells were transduced with Flap+ or Flap-
HIV-derived vectors (TRIP-eGFP and HR-eGFP, respectively) [9] in 6-
well plates with 0.1, 1, 10, 100 or 1000 ng/0.3 × 106 cells. The
percentage of GFP-positive cells and the mean fluorescent intensity
were assessed 48 h post-transduction by flow cytometry (BD
Calibur).
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independent nuclear import reported here may be
observed in both cycling and non-cycling cells
[9,10,39,46]. We have noted that smaller lentiviral gen-
omes, such as minimal HIV-1 derived vectors, have a
higher proportion of DNA-Flap-independent nuclear
import (P. Charneau, unpublished data), suggesting that
the smaller the viral genome, the less dependent it is on
the central DNA Flap for passage through the nuclear
pore.
Taken together, our data establish that the integrity of
the central DNA Flap is required to support a spreading
infection and confirm that all cPPT and CTS mutants
have a nuclear import defect. Although this defect may
vary in its amplitude depending on the nuclear import
assay and the MOI used, it is consistently observed. Of
note, central (+) strand initiation may also carry further
benefits for HIV-1 replication besides assisting viral
nuclear import, such as protection from APOBEC3G/F
editing as previously shown [14,16]. Here, we show that
even the most disrupted DNA Flap mutants still main-
tain residual nuclear import, but that this does not sup-
port spreading infection in human lymphocytic cells. It
will be interesting to determine the mechanisms for this
DNA Flap-independent nuclear import.
Methods
Cells and viruses
The P4-CCR5 reporter cells are HeLa CD4+ CXCR4+
CCR5+ carrying the Lac Z gene under the control of
the HIV-1 LTR promoter [6]. MT4 cells are HTLV-1
transformed human CD4+ T cells that allow acute cyto-
pathic HIV-1 infection [54]. The 293T cells are human
embryonic kidney cells. Citrate human blood was
obtained from healthy donors (Etablissement Français
du Sang) and PBMCs were isolated following Ficoll gra-
dient. GHOST3 cells are HOS CD4+ CXCR4+ CCR5+
carrying the green fluorescent protein (GFP) gene under
the control of the HIV-2 LTR promoter.
The viral molecular clone used in our study was HIV-
1BRU also called LAV (Lymphadenopathy-associated
virus), based on the 1983 isolate from a homosexual
patient with lymphadenopathy [55]. This molecular
clone is HIV-1LAI for all intents and purposes and is
referred to as such in the manuscript. In the case of
pseudotyping with VSV-G, we used a ∆env molecular
clone that was generated by deletion of the 1.3 kb KpnI-
BglII fragment in HIV-1 env [56]. Molecular clones
from the Hu et al., 2010 study are NL4-3 Vpr-, WT,
mcPPT (cPPT mutant) or DM (cPPT and CTS double
mutant).
The generation of 223 [7], 225T [17], cPPT-D [9] and
CTS [6] mutants by site directed mutagenesis has been
described previously. Double mutants were generated by
splice overlap extension PCR using the following
primers to amplify the cPPT region, DM1 5’-ACATA-
CAGACAATGGCAG-3’ and DM2 5’-TGCTATTATGT
CTACTATTC-3’ and the following primers to amplify
the CTS region, DM3 5’-ATAGTAGACATAATAG-
CAAC-3’ and DM4 5’-TATGTCGACACCCAATTC-3’.
Virus production
Viruses were produced by transient transfection of 293T
cells using calcium phosphate co-precipitation with the
wild-type or mutant proviral plasmids based on pLAI or
pNL43 Vpr-. In the case of pseudotyping with VSV-G,
pLAI∆env was co-transfected with the VSV-G envelope
expression plasmid pHCMV-G [57]. Virus concentration
in supernatants was measured by p24 ELISA according
to the manufacturer’s instructions (Perkin Elmer).
Quantitative PCR
P4-CCR5 cells were infected with LAI-vsvG viruses (500
ng p24 antigen per 2 × 106 cells in 2 ml) for 2 h at 37°C
and thereafter maintained at a concentration of 0.33 ×
106 cells/ml. For each viral strain, a control of infected
cells cultured in the presence of 5 μM nevirapine, a
nonnucleosidic RT inhibitor, was included. Total cellular
DNA was extracted at given time points post-infection
according to manufacturer’s instruction (Qiagen) 2-LTR
junctions were quantified by real-time PCR using a
Realplex instrument (Eppendorf) with 5’AACTAGG-
GAACCCACTGCTTAAG3’ forward primer, 5’TCCA-
CAG ATCAAGGATATCTTGTC3’ reverse primer and
5’FAM ACACTACTTGAAGCACTCAAGGC AAGCT
TT TAMRA3’ probe [58]. Pol gene copy number was
determined with 5’TTTAGATGGA ATAGATAAG
GCCCAA3’ forward primer, 5’CAGCTGGCTAAC-
TATTTCTTTTGCTA3’ reverse primer and 5’FAM
AATCACTAGCCATTGCTCTCCAATTAC TAMRA3’.
Amplification was carried out for each reaction in 20 μl
with 300 nM of each primer, 200 nM of probe, 5 μl of
total-cell DNA and 10 μl of 2X of FastStart Universal
Probe Master (Roche). Assessment of integration by
Alu-PCR was performed as previously described [59] at
24 h post-infection.
Restriction enzyme analysis of intracellular viral DNA
forms by Southern blotting
MT4 cells were infected with HIV-1LAI vsvG viruses
(500 ng p24 antigen per 107 cells in 1 ml) for 2 h at 37°
C and thereafter maintained at a concentration of 0.5 ×
106 cells/ml. At 48 h post-infection, total DNA was iso-
lated by lysis in 10 mM Tris, 10 mM EDTA and 0.6%
SDS. Samples were treated by RNase A (100 μg/ml) for
1 h at 37°C, and proteinase K (100 μg/ml) for 2 h at 55°
C. DNA was extracted by phenol chloroform and
digested with DpnI to remove contaminating bacterial
plasmid DNA. Viral DNA was then digested with MscI
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and XhoI, which create well-defined fragments on the
basis of which the different intracellular forms of viral
DNA can be distinguished [9]. Digested samples were
then analysed by Southern blotting, using a probe that
overlaps one of the two MscI sites in the HIV-1 genome
[9]. Southern blots were quantified by phosphorimager
(Molecular Dynamics) and the ImageQuant software.
Single-cycle titration in P4-CCR5 and GHOST3 cells
P4-CCR5 infections were carried out in triplicate in 96-
well plates (10,000 cells per well) with increasing doses
of LAI or LAI-vsvG. b-Galactosidase activity was mea-
sured at 48 h postinfection by using a chemiluminescent
b-galactosidase reporter gene assay according to manu-
facturer’s instructions (Roche). GHOST3 infections were
carried out in 6-well plates (400,000 cells per well) with
increasing doses of LAI or NL43 Vpr-. The percentage
of GFP+ cells was assessed 48 h p.i using flow cytometry
(BD Calibur).
Replication kinetics
MT4 cells were infected with HIV-1LAI and cPPT/CTS
mutants in 96-well plates (1 ng p24 antigen per 5 × 104
cells in 200 μl). Every 2 days for 24 days, 100 μl of
supernatant were collected and replaced by fresh med-
ium. Viral concentration in supernatants was assessed
by RT-assay. PBMCs, stimulated for 3 days with Conca-
navalin A (5 μg/ml), were infected with HIVLAI and
cPPT/CTS mutants in 96-well plates (1 ng p24 antigen
per 1 × 105 cells in 200 μl). Every 3-4 days for 40 days,
100 μl of supernatant were collected and replaced with
fresh medium containing IL2 (final concentration 10 ng/
ml). Viral concentration in supernatants was assessed by
p24 ELISA (Perkin Elmer).
Additional material
Additional file 1: Figure S1: cPPT and CTS mutations do not affect
viral production. The p24 concentrations (ng/ml) are shown for 3 to 6
independent preparations of each virus, both wild-type and VSV-G
pseudotyped envelopes. The graph shows mean values +/- SEM. One-
way Anova analysis indicated that there is no statistically significant
difference between any of the 16 mean values.
Additional file 2: Figure S2: GHOST cells were infected in parallel
with viruses. GHOST cells were infected in parallel with viruses from the
Hu et al., 2010 study (WT, mcPPT, DM) and our wild-type and mutant
viruses (LAI, D, DM D). The percentage of GFP-positive cells was assessed
at 48 h p.i using flow cytometry. Results are representative of three
independent experiments.
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